JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Healthcare | 12.84% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
CALL
Clorox
CLX
$12.8B
| $996K | ﹤0.01% |
7,100
| – | – |
|
|
PRA
3852
DELISTED
ProAssurance
PRA
| $995K | ﹤0.01% |
57,002
+6,061
| +12% | +$119K |
|
3853
Zeta Global
ZETA
$7.29B
| $992K | ﹤0.01% |
121,446
+15,064
| +14% | +$122K |
|
3854
PIMCO Short Term Municipal Bond Active Exchange-Traded Fund
SMMU
$1.17B
| $990K | ﹤0.01% |
20,089
+3,249
| +19% | +$159K |
|
3855
PUT
First Solar
FSLR
$24.2B
| $989K | ﹤0.01% |
+6,600
| New | +$978K |
|
3856
CALL
Royal Caribbean
RCL
$81.6B
| $989K | ﹤0.01% |
20,000
| – | – |
|
3857
Joby Aviation
JOBY
$7.83B
| $987K | ﹤0.01% |
294,718
+14,953
| +5% | +$60.6K |
|
3858
Pitney Bowes
PBI
$2.25B
| $987K | ﹤0.01% |
259,825
-69,068
| -21% | -$233K |
|
|
WOW
3859
DELISTED
WideOpenWest
WOW
| $987K | ﹤0.01% |
108,323
+4,731
| +5% | +$53.6K |
|
3860
Alkami Technology
ALKT
$2.21B
| $983K | ﹤0.01% |
67,380
+36,003
| +115% | +$502K |
|
3861
SkinHealth Systems
SKIN
$86.8M
| $982K | ﹤0.01% |
107,945
-45,197
| -30% | -$488K |
|
|
CCRN
3862
DELISTED
Cross Country Healthcare
CCRN
| $981K | ﹤0.01% |
36,949
+16,781
| +83% | +$548K |
|
3863
CALL
Fluor
FLR
$7B
| $981K | ﹤0.01% |
+28,300
| New | +$904K |
|
3864
CALL
Builders FirstSource
BLDR
$7.8B
| $980K | ﹤0.01% |
+15,100
| New | +$943K |
|
|
CVGW
3865
DELISTED
Calavo Growers
CVGW
| $980K | ﹤0.01% |
33,356
+17,201
| +106% | +$576K |
|
3866
Nurix Therapeutics
NRIX
$2.81B
| $979K | ﹤0.01% |
89,096
+60,822
| +215% | +$734K |
|
3867
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
| $978K | ﹤0.01% |
23,912
-19,488
| -45% | -$797K |
|
|
TIPL
3868
DELISTED
Direxion Daily TIPS Bull 2X Shares
TIPL
| $978K | ﹤0.01% |
50,000
| – | – |
|
3869
PUT
Ball Corp
BALL
$16.4B
| $977K | ﹤0.01% |
19,100
| – | – |
|
3870
ReNew
RNW
$2.48B
| $976K | ﹤0.01% |
177,423
+128,412
| +262% | +$750K |
|
3871
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.28B
| $974K | ﹤0.01% |
47,379
+14,745
| +45% | +$290K |
|
3872
Upstart Holdings
UPST
$2.96B
| $974K | ﹤0.01% |
73,734
-96,871
| -57% | -$1.87M |
|
3873
Deluxe
DLX
$1.1B
| $972K | ﹤0.01% |
57,187
-1,515
| -3% | -$27K |
|
3874
PUT
Sarepta Therapeutics
SRPT
$1.91B
| $972K | ﹤0.01% |
7,500
-1,600
| -18% | -$185K |
|
3875
iShares Morningstar Small-Cap Value ETF
ISCV
$712M
| $970K | ﹤0.01% |
18,630
-496
| -3% | -$26.1K |
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,940 increased, 2,285 reduced and 594 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 594 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.